Skip to main content
Livermore
Livermore
ZHEN

Champlain Investment Partners, LLC

SEC CIK
0001315478
Latest filing
Aug 12, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Champlain Investment Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
346,640
Value
$31.4M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of EW by Champlain Investment Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026346,640$31.4M0.8%−686,857−66.5%ReducedHolders
Q1 20261,033,497$82.8M1.1%−700,715−40.4%ReducedHolders
Q4 20251,734,212$147.8M1.5%−380,325−18.0%ReducedHolders
Q3 20252,114,537$164.4M1.2%−109,167−4.9%ReducedHolders
Q2 20252,223,704$173.9M1.2%−388,085−14.9%ReducedHolders
Q1 20252,611,789$189.3M1.4%−209,924−7.4%ReducedHolders
Q4 20242,821,713$208.9M1.3%−258,990−8.4%ReducedHolders
Q3 20243,080,703$203.3M1.2%+132,515+4.5%AddedHolders
Q2 20242,948,188$272.3M1.7%−15,980−0.5%ReducedHolders
Q1 20242,964,168$283.3M1.6%+88,205+3.1%AddedHolders
Q4 20232,875,963$219.3M1.3%+108,640+3.9%AddedHolders
Q3 20232,767,323$191.7M1.2%−3,170−0.1%ReducedHolders
Q2 20232,770,493$261.3M1.6%+6,840+0.2%AddedHolders
Q1 20232,763,653$228.6M1.4%−189,150−6.4%ReducedHolders
Q4 20222,952,803$220.3M1.4%−32,213−1.1%ReducedHolders
Q3 20222,985,016$246.7M1.7%−63,930−2.1%ReducedHolders
Q2 20223,048,946$289.9M1.9%−36,111−1.2%ReducedHolders
Q1 20223,085,057$363.2M1.9%+31,560+1.0%AddedHolders
Q4 20213,053,497$395.6M1.8%−16,775−0.5%ReducedHolders
Q3 20213,070,272$347.6M1.7%−108,855−3.4%ReducedHolders
Q2 20213,179,127$329.3M1.6%−16,080−0.5%ReducedHolders
Q1 20213,195,207$267.2M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.